Funder
Centers for Disease Control and Prevention
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference18 articles.
1. CDC. 2019. Antibiotic resistance threats in the United States, 2019. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf
2. Bush K, Bradford PA (2020) Epidemiology of beta-Lactamase-Producing Pathogens. Clin Microbiol Rev 33(2):e00047–e00019
3. Tamma PD, Kazmi A, Bergman Y, Goodman KE, Ekunseitan E, Amoah J, Simner PJ (2019) The likelihood of developing a carbapenem-resistant Enterobacteriaceae infection during a hospital stay. Antimicrob Agents Chemother 63(8):e00757–e00719
4. CDC. 2015. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). November 2015 Update - CRE Tookit
5. Solter E, Adler A, Rubinovitch B, Temkin E, Schwartz D, Ben-David D, Masarwa S, Carmeli Y, Schwaber MJ (2018) Israeli national policy for carbapenem-resistant Enterobacteriaceae screening, carrier isolation and discontinuation of isolation. Infect Control Hosp Epidemiol 39:85–89
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献